Amexdrug Financial Statements From 2010 to 2024

AXRX Stock  USD 0  0.00  0.00%   
Amexdrug financial statements provide useful quarterly and yearly information to potential Amexdrug investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Amexdrug financial statements helps investors assess Amexdrug's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Amexdrug's valuation are summarized below:
Amexdrug does not presently have any fundamental signals for analysis.
Check Amexdrug financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amexdrug's main balance sheet or income statement drivers, such as , as well as many indicators such as . Amexdrug financial statements analysis is a perfect complement when working with Amexdrug Valuation or Volatility modules.
  
This module can also supplement various Amexdrug Technical models . Check out the analysis of Amexdrug Correlation against competitors.

Amexdrug Company Current Valuation Analysis

Amexdrug's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Amexdrug Current Valuation

    
  34.51 M  
Most of Amexdrug's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amexdrug is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Amexdrug has a Current Valuation of 34.51 M. This is 99.76% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.79% higher than that of the company.

Amexdrug Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Amexdrug's current stock value. Our valuation model uses many indicators to compare Amexdrug value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amexdrug competition to find correlations between indicators driving Amexdrug's intrinsic value. More Info.
Amexdrug is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.39  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Amexdrug is roughly  2.56 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amexdrug by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amexdrug's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Amexdrug Financial Statements

Amexdrug investors use historical fundamental indicators, such as Amexdrug's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Amexdrug. Please read more on our technical analysis and fundamental analysis pages.
Amexdrug Corporation, a pharmaceutical and cosmeceutical company, through its subsidiaries, primarily distributes pharmaceutical products. Amexdrug Corporation was founded in 1963 and is based in Commerce, California. AMEXDRUG CORPORATION operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 9 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amexdrug Pink Sheet Analysis

When running Amexdrug's price analysis, check to measure Amexdrug's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amexdrug is operating at the current time. Most of Amexdrug's value examination focuses on studying past and present price action to predict the probability of Amexdrug's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amexdrug's price. Additionally, you may evaluate how the addition of Amexdrug to your portfolios can decrease your overall portfolio volatility.